FORWARD PHARMA A/S: Financial statements 2020
CVR: 28865880
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -7,763,728 and a net result of DKK -42,201,691 compared with DKK -28,465,258 the year before. Equity in the 2020 report amounted to DKK 474,106,683. The solvency ratio was 82.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -7,763,728
- Profit/Loss
- DKK -42,201,691
- Equity
- DKK 474,106,683
- Total Assets
- DKK 574,865,811
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -7.8 mio. | -42.2 mio. | 474.1 mio. | 2 |
| 2019 | - | -6 mio. | -28.5 mio. | 515.9 mio. | 3 |
| 2018 | 0 | -7.6 mio. | -54.3 mio. | 534.6 mio. | 3 |
| 2017 | 1.3 mia. USD | - | 880.2 mio. USD | 89.4 mio. USD | - |
| 2016 | - | - | 2 mio. USD | 189.7 mio. USD | - |
Official annual report
How creditworthy is FORWARD PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
FORWARD PHARMA A/S has published its annual report for 2019. Gross profit came to DKK -5,969,155, and the net result was DKK -28,465,258.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.